Overview
Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome is an extremely rare condition that combines three main problems affecting different parts of the body. First, Moebius syndrome causes weakness or paralysis of the facial nerves, which means people with this condition often cannot move their face normally — they may have trouble smiling, frowning, blinking, or moving their eyes side to side. Second, axonal neuropathy means the long nerve fibers (axons) that carry signals to the arms and legs are damaged, leading to numbness, tingling, muscle weakness, and difficulty with coordination, especially in the hands and feet. Third, hypogonadotropic hypogonadism is a hormonal problem where the brain does not produce enough signaling hormones (called gonadotropins) to stimulate the sex glands properly. This leads to delayed or absent puberty, and can affect fertility. The condition is present from birth or early childhood. Because it affects multiple body systems — the nervous system, the hormonal system, and facial movement — patients typically need care from several different specialists. Treatment focuses on managing each component of the syndrome individually, as there is currently no cure. Hormone replacement therapy can address the hypogonadism, while physical therapy and supportive care help manage the neuropathy and facial weakness.
Key symptoms:
Inability to move the face or make facial expressionsDifficulty moving the eyes side to sideTrouble closing the eyes completelyFeeding difficulties in infancyNumbness or tingling in hands and feetMuscle weakness in the arms and legsPoor balance and coordinationDelayed or absent pubertyUnderdeveloped sexual characteristicsReduced or absent sense of smell in some casesSpeech difficultiesDrooling due to poor facial muscle controlMuscle wasting in the lower legs or handsInfertility or reduced fertility
Clinical phenotype terms (15)— hover any for plain English
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome.
Community
No community posts yet. Be the first to share your experience with Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome.
Start the conversation →Latest news about Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome
No recent news articles for Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How severe is the nerve damage, and is it likely to get worse over time?,When should hormone replacement therapy be started, and what are the options?,What surgical options exist to improve facial movement or eye closure?,What therapies can help maintain strength and function in the arms and legs?,Will my child be able to have children in the future with treatment?,Should genetic testing be done for family members?,What specialists should be part of the care team, and how often should we see them?
Common questions about Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome
What is Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome?
Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome is an extremely rare condition that combines three main problems affecting different parts of the body. First, Moebius syndrome causes weakness or paralysis of the facial nerves, which means people with this condition often cannot move their face normally — they may have trouble smiling, frowning, blinking, or moving their eyes side to side. Second, axonal neuropathy means the long nerve fibers (axons) that carry signals to the arms and legs are damaged, leading to numbness, tingling, muscle weakness, and difficulty with
At what age does Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome typically begin?
Typical onset of Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome is neonatal. Age of onset can vary across affected individuals.